The use of iPS cells may constitute a therapeutic weapon against many serious medical conditions in the near future. To date, scientists have been able to induce iPS cells to differentiate into insulin-producing cells (Proc Natl Acad S, USA, 2009; 106, 157668-157773); that is, create pancreatic β cells from iPS cells (Nature Biotechnology 2008; 26, 443-452). Now, according to a paper published in the Journal of Investigation (2013; 123, 3146-3153), a team from New York University has been able to induce the differentiation of iPS cells taken from patients with type 2 juvenile diabetes, an outcome that will surely facilitate the study of this serious juvenile disorder.